Company Quick10K Filing
PerkinElmer
10-Q 2020-07-05 Filed 2020-08-11
10-Q 2020-04-05 Filed 2020-05-12
10-K 2019-12-29 Filed 2020-02-25
10-Q 2019-09-29 Filed 2019-11-05
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-30 Filed 2019-02-26
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-07-01 Filed 2018-08-07
10-Q 2018-04-01 Filed 2018-05-08
10-K 2017-12-31 Filed 2018-02-27
10-Q 2017-10-01 Filed 2017-11-07
10-Q 2017-07-02 Filed 2017-08-08
10-Q 2017-04-02 Filed 2017-05-09
10-K 2017-01-01 Filed 2017-02-28
10-Q 2016-10-02 Filed 2016-11-08
10-Q 2016-07-03 Filed 2016-08-09
10-Q 2016-04-03 Filed 2016-05-10
10-K 2016-01-03 Filed 2016-03-01
10-Q 2015-10-04 Filed 2015-11-10
10-Q 2015-06-28 Filed 2015-08-04
10-Q 2015-03-29 Filed 2015-05-05
10-K 2014-12-28 Filed 2015-02-24
10-Q 2014-09-28 Filed 2014-11-04
10-Q 2014-06-29 Filed 2014-08-05
10-Q 2014-03-30 Filed 2014-05-06
10-K 2013-12-29 Filed 2014-02-25
10-Q 2013-09-29 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-08-06
10-Q 2013-03-31 Filed 2013-05-06
10-K 2012-12-30 Filed 2013-02-26
10-Q 2012-09-30 Filed 2012-11-06
10-Q 2012-07-01 Filed 2012-08-07
10-Q 2012-04-01 Filed 2012-05-08
10-K 2012-01-01 Filed 2012-02-28
10-Q 2011-10-02 Filed 2011-11-04
10-Q 2011-07-03 Filed 2011-08-10
10-Q 2011-04-03 Filed 2011-05-10
10-K 2011-01-02 Filed 2011-03-01
10-Q 2010-10-03 Filed 2010-11-10
10-Q 2010-07-04 Filed 2010-08-10
10-Q 2010-04-04 Filed 2010-05-13
10-K 2010-01-03 Filed 2010-03-01
8-K 2020-07-28 Earnings, Exhibits
8-K 2020-07-13 Earnings, Exhibits
8-K 2020-05-05
8-K 2020-04-28
8-K 2020-03-26
8-K 2020-03-25
8-K 2020-03-09
8-K 2020-03-01
8-K 2020-01-27
8-K 2019-10-30
8-K 2019-09-17
8-K 2019-09-12
8-K 2019-08-21
8-K 2019-07-29
8-K 2019-04-25
8-K 2019-04-23
8-K 2019-04-08
8-K 2019-01-31
8-K 2018-12-07
8-K 2018-10-31
8-K 2018-08-01
8-K 2018-04-30
8-K 2018-04-24
8-K 2018-04-11
8-K 2018-04-10
8-K 2018-01-25

PerkinElmer Financials

PKI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Illumina (ILMN) 44,722 69% 35.1 14% 7,089 2,650 3,458 2,395 973 1,255 44,038
Agilent Technologies (A) 24,292 54% 18.0 9% 9,452 4,704 5,163 2,805 877 1,368 24,690
Mettler Toledo (MTD) 17,554 58% 26.5 21% 2,636 2,198 2,983 1,720 550 700 18,558
Waters (WAT) 15,473 18% 31.8 15% 2,561 2,446 2,405 428 392 513 16,324
Bio-Rad Laboratories (BIO) 10,341 55% 12.0 5% 7,177 2,046 2,304 1,259 377 850 10,215
PerkinElmer (PKI) 9,500 48% 25.3 4% 6,489 3,782 2,835 1,374 234 449 11,362
Bruker (BRKR) 6,836 48% 23.2 9% 2,352 1,507 2,026 972 207 305 7,055
Coherent (COHR) 3,296 34% 37.6 3% 2,083 798 1,431 486 54 79 2,977
Accelerate Diagnostics (AXDX) 1,034 45% -15.4 -58% 147 137 8 3 -85 -72 1,112
Pacific Biosciences of California (PACB) 862 33% -7.4 -79% 146 95 82 27 -115 -113 840
Fluidigm (FLDM) 852 40% -16.2 -19% 269 107 117 46 -52 -51 824
Quanterix (QTRX) 607 39% -12.8 -22% 176 39 52 20 -39 -39 501
EyePoint Pharmaceuticals (EYPT) 194 67% -2.9 -101% 79 63 12 8 -80 -72 209
Harvard Bioscience (HBIO) 130 55% 33.8 -1% 163 86 119 66 -2 5 175
HTG Molecular Diagnostics (HTGM) 36 48% 0.2 -29% 51 23 14 7 -15 -13 -2
Precipio (PRPO) 20 4% -2.2 -42% 23 7 6 0 -9 -9 19
Astrotech (ASTC) 11 17% -1.4 -144% 5 4 0 0 -7 -7 10
Bionano Genomics (BNGO) 7 29% 0.1 -81% 19 27 11 3 -16 -13 -1
Aethlon Medical (AEMD) 0 0% 0.1 -579% 1 1 0 0 -7 -7 -0

Balance Sheet ($MM)2010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-10-042016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Cash216251420416395248142145171171171126112132173224205204175169192195238211248312359288616709202181164153166137153396
Accounts Receivable365324357345383360410408389395457411435429470443444427471415426414439437436443426411440441552576564551633624654646
Inventory232210207225222229241252244261248260259278261279278282285291305313288314300306247265275295352375367354338377414392
PP&E595414162432443442452458457501513519528508504507508506493485492495495508509525428449461475631655707724680649671669
Assets3,1463,2483,2093,3063,5963,4023,8343,8643,8013,8903,9023,8083,8113,8523,9473,9713,9373,8864,1344,0284,0834,0324,1664,2114,1944,3054,2774,3414,6054,7396,0916,1265,9585,8625,9766,0866,3996,489
Accounts Payable175143161149149151173163174156169172170163167168155161174157171150153159156162168158154164222215197181221219188190
Long-Term Debt6206704245141505089489349119329411,0271,0049369359308958601,0531,0169881,0281,0135885251,1331,0461,0551,0921,1112,0062,0772,0011,9031,8911,8622,1132,258
Liabilities1,5021,5411,2841,3981,6391,4571,9921,9821,9161,9481,9621,9741,9511,9321,9521,9421,8811,8242,0921,9681,9621,9772,0562,1612,1062,1692,1232,1322,1662,2033,5883,5713,4413,2903,3913,4483,6923,782
Stockholders' Equity1,6441,7071,9261,9081,9561,9451,8421,8831,8851,9421,9401,8341,8601,9201,9942,0292,0562,0632,0422,0602,1212,0542,1102,0492,0882,1352,1542,2092,4392,5362,5032,5552,5172,5722,5852,6382,7072,707
Income Statement ($MM)2010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-10-042016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Revenue498419470448508454540511522510573505543524593532563542608527564563608539573548567514547554642644703674756649723707
Cost of Revenue285233262248285254300279308279103280301291103296312299106292311309112289307287109275289285127352363342380341375365
Gross Profit213186208200223200240232214231262225242234276236250243278235253255282250265261276240258269307292340332376308348342
R&D27242626313031333432343436323329303031323331303435332233343538464749484845
SG&A133121125135154135217157150145181151149144142153147143217146147148159148154146154145148151172200205197199202204
Tax108285447152-27-8-05-115105-118896105121489119273135
Net Income5813288243935-84233430-16323140673450423140495568476458653920491-4126647771356959
Cash Flow ($MM)2010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-10-042016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Cash Operating152947524883167621401128487268546397386461126329474149544859128-157393-547107
Cash Investing-34453-64-233-5-607-5-5-18-52-10-1237-16-6-9-9-272-9-20-7-65-1710-70-23-11427445-1,454-24-568-29-257-29
Cash Financing38-308-2153-171419-10-39-712-43-28-68-15-12-65-47155-25-24-44-15-48-6560-62-16-3-1681713-26-1095226170